Literature DB >> 19067370

Detection of isolated cerebrovascular beta-amyloid with Pittsburgh compound B.

Steven M Greenberg1, Thomas Grabowski, M Edip Gurol, Maureen E Skehan, R N Kaveer Nandigam, John A Becker, Monica Garcia-Alloza, Claudia Prada, Matthew P Frosch, Jonathan Rosand, Anand Viswanathan, Eric E Smith, Keith A Johnson.   

Abstract

Imaging of cerebrovascular beta-amyloid (cerebral amyloid angiopathy) is complicated by the nearly universal overlap of this pathology with Alzheimer's pathology. We performed positron emission tomographic imaging with Pittsburgh Compound B on 42-year-old man with early manifestations of Iowa-type hereditary cerebral amyloid angiopathy, a form of the disorder with little or no plaque deposits of fibrillar beta-amyloid. The results demonstrated increased Pittsburgh Compound B retention selectively in occipital cortex, sparing regions typically labeled in Alzheimer's disease. These results offer compelling evidence that Pittsburgh Compound B positron emission tomography can noninvasively detect isolated cerebral amyloid angiopathy before overt signs of tissue damage such as hemorrhage or white matter lesions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19067370      PMCID: PMC2605158          DOI: 10.1002/ana.21528

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  21 in total

1.  Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria.

Authors:  K A Knudsen; J Rosand; D Karluk; S M Greenberg
Journal:  Neurology       Date:  2001-02-27       Impact factor: 9.910

2.  Cerebral hemorrhage after passive anti-Abeta immunotherapy.

Authors:  M Pfeifer; S Boncristiano; L Bondolfi; A Stalder; T Deller; M Staufenbiel; P M Mathews; M Jucker
Journal:  Science       Date:  2002-11-15       Impact factor: 47.728

3.  Imaging of amyloid burden and distribution in cerebral amyloid angiopathy.

Authors:  Keith A Johnson; Matt Gregas; John A Becker; Catherine Kinnecom; David H Salat; Erin K Moran; Erin E Smith; Jonathan Rosand; Dorene M Rentz; William E Klunk; Chester A Mathis; Julie C Price; Steven T Dekosky; Alan J Fischman; Steven M Greenberg
Journal:  Ann Neurol       Date:  2007-09       Impact factor: 10.422

4.  Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy.

Authors:  T J Grabowski; H S Cho; J P Vonsattel; G W Rebeck; S M Greenberg
Journal:  Ann Neurol       Date:  2001-06       Impact factor: 10.422

Review 5.  Current concepts in mild cognitive impairment.

Authors:  R C Petersen; R Doody; A Kurz; R C Mohs; J C Morris; P V Rabins; K Ritchie; M Rossor; L Thal; B Winblad
Journal:  Arch Neurol       Date:  2001-12

6.  Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report.

Authors:  James A R Nicoll; David Wilkinson; Clive Holmes; Phil Steart; Hannah Markham; Roy O Weller
Journal:  Nat Med       Date:  2003-03-17       Impact factor: 53.440

7.  Four-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-beta ligand in transgenic mice.

Authors:  Brian J Bacskai; Gregory A Hickey; Jesse Skoch; Stephen T Kajdasz; Yanming Wang; Guo-Feng Huang; Chester A Mathis; William E Klunk; Bradley T Hyman
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-29       Impact factor: 11.205

8.  Carbon 11-labeled pittsburgh compound B positron emission tomographic amyloid imaging in patients with APP locus duplication.

Authors:  Anne M Remes; Lauri Laru; Hannu Tuominen; Sargo Aalto; Nina Kemppainen; Helinä Mononen; Kjell Någren; Riitta Parkkola; Juha O Rinne
Journal:  Arch Neurol       Date:  2008-04

9.  Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B.

Authors:  William E Klunk; Henry Engler; Agneta Nordberg; Yanming Wang; Gunnar Blomqvist; Daniel P Holt; Mats Bergström; Irina Savitcheva; Guo-feng Huang; Sergio Estrada; Birgitta Ausén; Manik L Debnath; Julien Barletta; Julie C Price; Johan Sandell; Brian J Lopresti; Anders Wall; Pernilla Koivisto; Gunnar Antoni; Chester A Mathis; Bengt Långström
Journal:  Ann Neurol       Date:  2004-03       Impact factor: 10.422

10.  PIB is a non-specific imaging marker of amyloid-beta (Abeta) peptide-related cerebral amyloidosis.

Authors:  A Lockhart; J R Lamb; T Osredkar; L I Sue; J N Joyce; L Ye; V Libri; D Leppert; T G Beach
Journal:  Brain       Date:  2007-08-13       Impact factor: 13.501

View more
  45 in total

1.  Structural network alterations and neurological dysfunction in cerebral amyloid angiopathy.

Authors:  Yael D Reijmer; Panagiotis Fotiadis; Sergi Martinez-Ramirez; David H Salat; Aaron Schultz; Ashkan Shoamanesh; Alison M Ayres; Anastasia Vashkevich; Diana Rosas; Kristin Schwab; Alexander Leemans; Geert-Jan Biessels; Jonathan Rosand; Keith A Johnson; Anand Viswanathan; M Edip Gurol; Steven M Greenberg
Journal:  Brain       Date:  2014-11-02       Impact factor: 13.501

Review 2.  Amyloid imaging as a biomarker for cerebral β-amyloidosis and risk prediction for Alzheimer dementia.

Authors:  William E Klunk
Journal:  Neurobiol Aging       Date:  2011-12       Impact factor: 4.673

3.  Amyloid-β contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy.

Authors:  Anika M S Hartz; Björn Bauer; Emma L B Soldner; Andrea Wolf; Sandra Boy; Roland Backhaus; Ivan Mihaljevic; Ulrich Bogdahn; Hans H Klünemann; Gerhard Schuierer; Felix Schlachetzki
Journal:  Stroke       Date:  2011-11-23       Impact factor: 7.914

4.  Spatial relation between microbleeds and amyloid deposits in amyloid angiopathy.

Authors:  Gregory A Dierksen; Maureen E Skehan; Muhammad A Khan; Jed Jeng; R N Kaveer Nandigam; John A Becker; Ashok Kumar; Krista L Neal; Rebecca A Betensky; Matthew P Frosch; Jonathan Rosand; Keith A Johnson; Anand Viswanathan; David H Salat; Steven M Greenberg
Journal:  Ann Neurol       Date:  2010-10       Impact factor: 10.422

Review 5.  Cerebral microbleeds and macrobleeds: should they influence our recommendations for antithrombotic therapies?

Authors:  Kellen E Haley; Steven M Greenberg; M Edip Gurol
Journal:  Curr Cardiol Rep       Date:  2013-12       Impact factor: 2.931

6.  Amyloid imaging of dutch-type hereditary cerebral amyloid angiopathy carriers.

Authors:  Aaron P Schultz; Reina W Kloet; Hamid R Sohrabi; Louise van der Weerd; Sanneke van Rooden; Marieke J H Wermer; Laure Grand Moursel; Maqsood Yaqub; Bart N M van Berckel; Pratishtha Chatterjee; Samantha L Gardener; Kevin Taddei; Anne M Fagan; Tammie L Benzinger; John C Morris; Reisa Sperling; Keith Johnson; Randall J Bateman; M Edip Gurol; Mark A van Buchem; Ralph Martins; Jasmeer P Chhatwal; Steven M Greenberg
Journal:  Ann Neurol       Date:  2019-08-12       Impact factor: 10.422

7.  Cerebral amyloid angiopathy burden associated with leukoaraiosis: a positron emission tomography/magnetic resonance imaging study.

Authors:  M Edip Gurol; Anand Viswanathan; Christopher Gidicsin; Trey Hedden; Sergi Martinez-Ramirez; Andrew Dumas; Anastasia Vashkevich; Alison M Ayres; Eitan Auriel; Ellis van Etten; Alex Becker; Jeremy Carmasin; Kristin Schwab; Jonathan Rosand; Keith A Johnson; Steven M Greenberg
Journal:  Ann Neurol       Date:  2013-02-19       Impact factor: 10.422

Review 8.  Using Pittsburgh Compound B for in vivo PET imaging of fibrillar amyloid-beta.

Authors:  Ann D Cohen; Gil D Rabinovici; Chester A Mathis; William J Jagust; William E Klunk; Milos D Ikonomovic
Journal:  Adv Pharmacol       Date:  2012

9.  Structural neuroimaging in Altheimer's disease: do white matter hyperintensities matter?

Authors:  Adam M Brickman; Jordan Muraskin; Molly E Zimmerman
Journal:  Dialogues Clin Neurosci       Date:  2009       Impact factor: 5.986

Review 10.  Amyloid imaging in aging and dementia: testing the amyloid hypothesis in vivo.

Authors:  G D Rabinovici; W J Jagust
Journal:  Behav Neurol       Date:  2009       Impact factor: 3.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.